Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ABBV
NVS
Add up to 3 more stocks
ABBV
AbbVie Inc.
+1.11%
$262.82+2.89Delayed quote: Oct 2, 2026, 4:02 PM EDT
Market Cap
$464.35B
52W Range
$190.75 - $269.39
NVS
Novartis AG
-0.04%
$141.00-0.05Delayed quote: Oct 2, 2026, 4:00 PM EDT
Market Cap
$268.00B
52W Range
$121.57 - $170.46
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 74.05 | 21.27 |
| Forward P/E | 18.71 | 16.01 |
| PEG Ratio | N/A | 1.38 |
| P/B Ratio | N/A | 6.45 |
| P/S Ratio | 7.21 | 4.82 |
| P/FCF Ratio | 25.50 | 16.94 |
| EV/EBITDA | 19.72 | 13.85 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 71.5% | 74.4% |
| Operating Margin | 29.3% | 30.5% |
| Net Margin | 9.8% | 22.9% |
| ROE | N/A | 30.7% |
| ROA | 4.7% | 10.5% |
| ROIC | 13.5% | 13.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 0.81 | 0.86 |
| Quick Ratio | 0.69 | 0.67 |
| Debt/Equity | N/A | 1.18 |
| Interest Coverage | 6.94 | 14.38 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 2.6% | 3.4% |
| Payout Ratio | 192.4% | 71.5% |
| Yrs of Dividend Growth | 52 | 1 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.